Archives
-
Linoleic Acid: Reliable Assay Workflows
2026-09-19
A scenario-driven guide to using Linoleic Acid (SKU C3108) in viability, migration, oxidative-stress, erythrocyte, and nutritional-deficiency workflows. It explains formulation constraints, dose-response design, interpretation of redox-sensitive readouts, and practical criteria for selecting a reliable reagent.
-
Roscovitine (Seliciclib, CYC202) for Reliable Assays
2026-09-18
This scenario-based guide explains how Roscovitine (Seliciclib, CYC202), SKU A1723, can improve the interpretation of cell-cycle, proliferation, and cytotoxicity experiments. It connects biochemical potency, formulation, controls, orthogonal readouts, and vendor-selection considerations without equating biochemical IC50 values with cellular dose requirements.
-
5-Aminolevulinic acid HCl in Heme Research
2026-09-18
5-Aminolevulinic acid HCl provides a controllable way to perturb tetrapyrrole flux rather than simply adding a heme end product. This article translates that principle into macrophage infection, bacterial virulence, photodynamic therapy, and fluorescence-guided tumor resection workflows, with practical controls for interpreting pathway-dependent results.
-
EdU Imaging Kits (488): Translational Insight
2026-09-17
A mechanistic and strategic guide to using EdU Imaging Kits (488) for S-phase DNA synthesis measurement, with a colorectal cancer case study showing how proliferation data can strengthen validation of the EIF4A3–circEIF2S2–miR-646–UHMK1 axis.
-
5-Aminolevulinic acid HCl in Cell Assays
2026-09-17
This scenario-based guide explains how 5-Aminolevulinic acid HCl (SKU B2070) can support controlled cell, heme-pathway, and macrophage experiments. It separates product specifications from literature-derived biological conclusions and provides practical formulation, dosing, storage, interpretation, and vendor-selection guidance.
-
Pazopanib in ATRX-Deficient Glioma Research
2026-09-16
Pazopanib (GW-786034) provides a practical way to interrogate RTK, PDGFR, and VEGF signaling in cancer models. This workflow connects ATRX genotype, pathway pharmacology, combination testing with temozolomide, and assay troubleshooting without treating a single viability value as definitive mechanism.
-
Aprotinin: Practical BPTI Workflows for Cell Research
2026-09-16
Aprotinin provides a reversible way to control trypsin, plasmin, and kallikrein during protease-sensitive experiments, from fibrinolysis inhibition to inflammation studies. This guide translates that chemistry into reproducible sample-preparation and red-blood-cell membrane workflows while separating validated product data from practical optimization advice.
-
Nelfinavir Mesylate in HIV and Ferroptosis Research
2026-09-15
Nelfinavir Mesylate supports two distinct research tracks: HIV-1 protease inhibition and experimental modulation of the DDI2–NFE2L1–proteasome response during ferroptosis. This workflow-focused guide explains how to separate antiviral activity from proteostasis effects, improve assay design, and troubleshoot solubility, controls, and interpretation.
-
Deep Learning for iPSC-CM Cardiotoxicity Screening
2026-09-15
Grafton et al. combined human induced pluripotent stem cell-derived cardiomyocytes, high-content imaging, and deep learning to identify cellular patterns associated with cardiotoxicity. The study shows how a scalable phenotypic score can support earlier safety triage across chemically and pharmacologically diverse compounds.
-
EdU Cell Proliferation Kit for S-Phase Research
2026-09-14
The EdU Cell Proliferation Kit (TMB) converts newly synthesized DNA into a quantitative, non-radioactive microplate signal for S-phase studies. Its click-chemistry workflow is especially useful for validating ARL4C-dependent synoviocyte proliferation, screening interventions, and separating cytostatic effects from broader cell injury.
-
Halazone and Sodium Current Inactivation in Frog Nerves
2026-09-14
The 1986 frog nerve study showed that Halazone and hypochlorous acid strongly disrupted sodium-current inactivation, producing a distinctive nonmonotonic voltage dependence. Its comparative reagent design argued against a uniquely critical methionine residue and instead supported membrane-lipid modification as a tentative mechanism.
-
SC 79: An Akt Activator for Research Workflows
2026-09-13
SC 79 is a cytosolic Akt activator designed to enhance Akt phosphorylation without changing total Akt abundance, making it useful for pathway causality studies rather than simple endpoint screening. This guide explains practical dosing, washout, neuroprotection, and ferroptosis workflows, with troubleshooting strategies for reproducible signaling data.
-
Vincristine Sulfate: Assays, Workflows & Optimization
2026-09-12
Build more reproducible vincristine assays by connecting microtubule dynamics to dose, time, imaging, and orthogonal viability readouts. This practical guide covers cell-based screens, translational xenograft planning, formulation control, and troubleshooting for cancer research.
-
Deep Learning for iPSC-CM Cardiotoxicity Screening
2026-09-11
Grafton and colleagues combined induced pluripotent stem cell-derived cardiomyocytes with high-content imaging and deep learning to identify cardiotoxic phenotypes during early drug discovery. Their single-parameter scoring strategy detected liabilities across multiple pharmacological classes and chemical frameworks, illustrating how scalable phenotypic screening can complement conventional target-based assays.
-
I-BET151 Workflows for BET Cancer Research
2026-09-11
I-BET151 (GSK1210151A) offers a practical way to perturb BRD2, BRD3, and BRD4-dependent transcription in leukemia, glioblastoma, and other cancer biology models. This guide connects dose-response design, apoptosis and cell cycle readouts, organoid assay logic, and troubleshooting with the emerging transcriptional insights from PDX1-mutant pancreas research.